Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.15 is 22% below its 5-year average of 4.03, around the middle of its 5-year range (0.00–9.37).
As of the fiscal period ended Tuesday, June 30, 2026. 10.94% below its 12-month average of 3.54.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.15.
QUICK RATIO (ACID-TEST)
3.15
QUICK RATIO (ACID-TEST) AVG TTM
3.54
QUICK RATIO (ACID-TEST) AVG 3Y
4.13
QUICK RATIO (ACID-TEST) AVG 5Y
4.03
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-10.94%
CURRENT VS 3Y AVG
-23.68%
CURRENT VS 5Y AVG
-21.75%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-6.05%
vs the sector median at left
Fractyl Health, Inc.
Market Cap
$60.42M
Quick Ratio (Acid-Test)
3.15
TTM Avg
3.54
3Y Avg
4.13
5Y Avg
4.03
Market Cap
$60.24M
Quick Ratio (Acid-Test)
10.98
TTM Avg
17.43
3Y Avg
9.10
5Y Avg
12.08
Market Cap
$60.02M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.97
3Y Avg
5.50
5Y Avg
8.52
Market Cap
$59.18M
Quick Ratio (Acid-Test)
4.25
TTM Avg
2.40
3Y Avg
3.43
5Y Avg
5.08
Market Cap
$58.44M
Quick Ratio (Acid-Test)
0.57
TTM Avg
2.81
3Y Avg
4.44
5Y Avg
7.47
Market Cap
$58.43M
Quick Ratio (Acid-Test)
6.71
TTM Avg
8.38
3Y Avg
9.61
5Y Avg
10.03
Market Cap
$58.29M
Quick Ratio (Acid-Test)
1.23
TTM Avg
0.89
3Y Avg
0.93
5Y Avg
1.06
Market Cap
$62.62M
Quick Ratio (Acid-Test)
5.53
TTM Avg
4.01
3Y Avg
3.97
5Y Avg
5.62
Market Cap
$62.78M
Quick Ratio (Acid-Test)
1.51
TTM Avg
1.60
3Y Avg
1.72
5Y Avg
2.07
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fractyl Health, Inc. (GUTS) | $60.42M | 3.15 | 3.54 | 4.13 | 4.03 |
| Kalaris Therapeutics Inc (KLRS)vs › | $60.24M | 10.98 | 17.43 | 9.10 | 12.08 |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | 1.35 | 1.97 | 5.50 | 8.52 |
| Xilio Therapeutics, Inc. (XLO)vs › | $59.18M | 4.25 | 2.40 | 3.43 | 5.08 |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | 0.57 | 2.81 | 4.44 | 7.47 |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | 6.71 | 8.38 | 9.61 | 10.03 |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | 1.23 | 0.89 | 0.93 | 1.06 |
| RenovoRx, Inc. (RNXT)vs › | $62.62M | 5.53 | 4.01 | 3.97 | 5.62 |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | 1.51 | 1.60 | 1.72 | 2.07 |
| InterCure Ltd. (INCR)vs › | $63.02M | 0.97 | 1.07 | 1.19 | 1.33 |
Quick Ratio
3.15
Excludes inventory
Current Ratio
3.15
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.15 |
| 2026-03-31 | 4.28 |
| 2025-12-31 | 4.78 |
| 2025-09-30 | 4.27 |
| 2025-06-30 | 1.22 |
| 2025-03-31 | 2.50 |
| 2024-12-31 | 3.63 |
| 2024-09-30 | 5.57 |
| 2024-06-30 | 7.46 |
| 2024-03-31 | 9.37 |
| 2023-12-31 | 3.18 |
| 2023-09-30 | 5.57 |
| 2023-06-30 | 3.96 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 7.06 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 4.07 |
| 2021-09-30 | 6.66 |
| 2021-06-30 | 7.87 |
| 2021-03-31 | 7.87 |
| 2020-12-31 | 2.83 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
